News
All NewsAAP NewsPNP Corner
Media
Cure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Diabetes
  • Gastroenterology
    • Formula
    • Nutrition
    • Obesity
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Vaccines
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement

Kevin Klembczyk, MD

Advertisement

Articles by Kevin Klembczyk, MD

Diagnosis and treatment of cannabinoid hyperemesis syndrome

ByKevin Klembczyk, MD,Jessica Calihan, MD,Rachel H. Alinsky, MD, MPH
April 7th 2022

Here is what pediatric health care providers need to know about this often debilitating disorder.

Advertisement

Latest Updated Articles

  • Diagnosis and treatment of cannabinoid hyperemesis syndrome
    Diagnosis and treatment of cannabinoid hyperemesis syndrome

    Published: April 7th 2022 | Updated:



Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

2

Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

3

Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults

4

Ruxolitinib Efficacy and Safety in Pediatric AD

5

Managing Pediatric AD With New Topicals

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us